Migdal Insurance & Financial Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $76.3M | Buy |
604,000
+160,000
| +36% | +$21.1M | 0.49% | 50 |
|
|
2026
Q1 | $61.9M | Buy |
444,000
+185,000
| +71% | +$25.9M | 0.54% | 46 |
|
|
2025
Q4 | $31.8M | Hold |
259,000
| – | – | 0.27% | 56 |
|
|
2025
Q3 | $28.7M | Buy |
+259,000
| New | +$29.4M | 0.31% | 55 |
|
|
2022
Q3 | – | Sell |
-2,521
| Closed | -$156K | – | 552 |
|
|
2022
Q2 | $156K | Buy |
2,521
+276
| +12% | +$17.1K | ﹤0.01% | 258 |
|
|
2022
Q1 | $134K | Sell |
2,245
-4,681
| -68% | -$299K | ﹤0.01% | 308 |
|
|
2021
Q4 | $504K | Sell |
6,926
-1,486
| -18% | -$102K | ﹤0.01% | 243 |
|
|
2021
Q3 | $588K | Sell |
8,412
-573
| -6% | -$40.3K | 0.01% | 239 |
|
|
2021
Q2 | $619K | Sell |
8,985
-272
| -3% | -$18.2K | 0.01% | 254 |
|
|
2021
Q1 | $598K | Buy |
9,257
+8,039
| +660% | +$518K | 0.01% | 301 |
|
|
2020
Q4 | $71K | Buy |
1,218
+218
| +22% | +$13.2K | ﹤0.01% | 456 |
|
|
2020
Q3 | $62K | Sell |
1,000
-1,627
| -62% | -$113K | ﹤0.01% | 545 |
|
|
2020
Q2 | $200K | Buy |
2,627
+990
| +60% | +$75.9K | ﹤0.01% | 354 |
|
|
2020
Q1 | $122K | Sell |
1,637
-1,014
| -38% | -$70.1K | ﹤0.01% | 363 |
|
|
2019
Q4 | $172K | Buy |
2,651
+168
| +7% | +$10.9K | ﹤0.01% | 438 |
|
|
2019
Q3 | $157K | Buy |
2,483
+858
| +53% | +$56.1K | ﹤0.01% | 503 |
|
|
2019
Q2 | $110K | Sell |
1,625
-4,819
| -75% | -$317K | ﹤0.01% | 560 |
|
|
2019
Q1 | $227K | Sell |
6,444
-70
| -1% | -$4.65K | 0.01% | 393 |
|
|
2018
Q4 | $231K | Sell |
6,514
-18,706
| -74% | -$1.31M | 0.01% | 353 |
|
|
2018
Q3 | $1.25M | Buy |
25,220
+8,573
| +51% | +$647K | 0.03% | 277 |
|
|
2018
Q2 | $696K | Buy |
16,647
+14,724
| +766% | +$1.04M | 0.02% | 283 |
|
|
2018
Q1 | $145K | Buy |
1,923
+483
| +34% | +$38.4K | ﹤0.01% | 387 |
|
|
2017
Q4 | $103K | Sell |
1,440
-21,723
| -94% | -$1.65M | ﹤0.01% | 375 |
|
|
2017
Q3 | $1.88M | Buy |
23,163
+21,082
| +1,013% | +$1.61M | 0.04% | 171 |
|
|
2017
Q2 | $147K | Buy |
+2,081
| New | +$138K | ﹤0.01% | 311 |
|
|
2017
Q1 | – | Sell |
-341
| Closed | -$25K | – | 473 |
|
|
2016
Q4 | $25K | Sell |
341
-245,257
| -100% | -$18.2M | ﹤0.01% | 370 |
|
|
2016
Q3 | $19.4M | Buy |
245,598
+53,403
| +28% | +$4.34M | 0.56% | 41 |
|
|
2016
Q2 | $16M | Sell |
192,195
-265
| -0.1% | -$23.5K | 0.44% | 47 |
|
|
2016
Q1 | $17.7M | Sell |
192,460
-391
| -0.2% | -$35.3K | 0.54% | 41 |
|
|
2015
Q4 | $19.5M | Buy |
+192,851
| New | +$20.1M | 0.56% | 43 |
|
Other funds holding GILD
Migdal Insurance & Financial Holdings's GILD Position: Q2 2026 in Review
Migdal Insurance & Financial Holdings increased its Gilead Sciences (GILD) stake by 36% in Q2 2026, buying an estimated $21.1M and bringing the position to 604,000 shares worth $76.3M. The position accounts for 0.49% of the portfolio, ranked #50.
Migdal Insurance & Financial Holdings first reported a position in GILD in Q4 2015 and has held it in 30 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Migdal Insurance & Financial Holdings held 604,000 shares of Gilead Sciences worth $76.3M as of Q2 2026.
- Migdal Insurance & Financial Holdings bought 160,000 Gilead Sciences shares in Q2 2026, an estimated $21.1M.
- Gilead Sciences made up 0.49% of Migdal Insurance & Financial Holdings's portfolio in Q2 2026, its #50 holding.
- Migdal Insurance & Financial Holdings first reported a position in Gilead Sciences in Q4 2015 and has held it in 30 quarters since.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2026, filed 10 Aug 2026.